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11/29/2016 Megajex Male Sex Enhancer Dietary Supplement Unapproved new drug MS Bionic, Inc
11/24/2016 CVS and Kids Relief Homeopathic products Misdeclared Belladonna extract levels Raritan Pharmaceuticals
11/18/2016 Cantrell Drug Company Sterile drug products Concern for Lack of Sterility Assurance Cantrell Drug Company
11/18/2016 Tri-Coast Pharmacy Inc. Sterile drug products Concern for lack of sterility assurance Tri-Coast Pharmacy Inc.
SHORTAGES
 FDA Drug shortage list
o http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
DRUG




 Skin patch could treat peanut allergy
o https://www.nih.gov/news-events/nih-research-matters/skin-patch-could-treat-peanut-allergy
 FDA Approves Hepatitis B Drug
o http://www.managedhealthcareconnect.com/content/fda-approves-hepatitis-b-drug
 Predicting the usefulness of antidepressants
o https://www.nih.gov/news-events/news-releases/predicting-usefulness-antidepressants
 Sanofi insulin buy back and rival price hikes a boon for MannKind's Afrezza
o http://www.in-pharmatechnologist.com/Drug-Delivery/Sanofi-insulin-buy-back-and-rival-price-hikes-a-boon-for-MannKind
 The FDA has approved a second manufacturer of AURYXIA and supply has been fully restored.
o AURYXIA is now available to order through your pharmacy wholesaler. For additional questions regarding AURYXIA, contact Keryx at
1-844-44KERYX (844-445-3799).
 AMA Adopts New Policy to Change Drug Pricing System
o http://www.managedhealthcareconnect.com/content/ama-adopts-new-policy-change-drug-pricing-system
 HHS takes additional steps to expand access to opioid treatment
o http://www.hhs.gov/about/news/2016/11/16/additional-steps-expand-opioid-treatment.html








 New FDA Watch List Covers 27 Drugs and Drug Classes
o http://www.medscape.com/viewarticle/869815?nlid=109788_745&src=WNL_mdplsfeat_161011_mscpedit_phar&uac=4045DY&spon
=30&impID=1213309&faf=1
 Warfarin Use for AF May Increase Dementia Risk
o http://www.consultant360.com/exclusives/warfarin-use-af-may-increase-dementia-risk




 FDA Approves Xultophy for Adults with Type 2 Diabetes
o http://www.consultant360.com/exclusives/fda-approves-xultophy-adults-type-2-diabetes
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 Post-Hospitalization PCP Visits Decrease 30-Day Readmission
o http://www.managedhealthcareconnect.com/content/post-hospital-visits-decrease-30-day-readmission
 Talks With Families Tied to Fewer Hospitalizations From Nursing Homes
o http://www.managedhealthcareconnect.com/content/talks-families-tied-fewer-hospitalizations-nursing-homes
FDA
 Inspections, Compliance, Enforcement, and Criminal Investigations
o http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/default.htm?source=govdelivery&utm_medium=email&utm_source=
govdelivery




 Tdap Vaccination During Pregnancy and Microcephaly and Other Structural Birth Defects in Offspring
o http://jamanetwork.com/journals/jama/article-abstract/2576582
 Injections Might Help Prevent Genital Herpes Transmission for Months: Study
o https://medlineplus.gov/news/fullstory_161815.html
 National Vaccine Supply Shortages
Vaccine Shortage Temporary Change From Routine Recommendation
Hepatitis B No
Rotavirus No
Diphtheria, Tetanus, & Pertussis (DTaP and Tdap) See note 2 See current information about Pentacel[4 pages] Dec 2015
Td See note 3
Haemophilus influenzae type B (Hib) No
Pneumococcal Conjugated (PCV) No
4
December 2016
Vaccine Shortage Temporary Change From Routine Recommendation
Pneumococcal Polysaccharide (PPV) No
Inactivated Polio (IPV) No
Measles, Mumps, & Rubella (MMR) See note
1
See Q&As about monovalent M-M-R vaccines Oct 2009
Influenza No See current information about influenza
Varicella/Zoster No
Hepatitis A No
Conjugated Meningococcal (MCV4) No
Human Papillomavirus (HPV) No
Note1: Based on input from the ACIP, professional societies, scientific leaders, and customers on October 26, 2009 Merck announced the company has decided not to resume production of ATTENUVAX® (Measles Virus Vaccine Live),
MUMPSVAX® (Mumps Virus Vaccine Live), and MERUVAX®II (Rubella Virus Vaccine Live). This science-based decision will support vaccination of the largest group of appropriate individuals. Updated Jan 2010
Note2: Sanofi Pasteur is experiencing a manufacturing delay with Pentacel (DTaP-IPV/Hib) vaccine, which is anticipated to result in constrained supplies that will extend into the second half of 2016. However, Sanofi Pasteur has sufficient supplies of
the relevant single antigen vaccines (DAPTACEL, ActHIB, and IPOL) to address the anticipated gap in Pentacel supply. Updated Jul 2016
Note3: Tenivac ® vaccine (Tetanus and Diphtheria Toxoids Adsorbed) is temporarily unavailable. It is anticipated that the product will become available in the second half of 2017. Grifols, who markets and distributes another US-licensed Td vaccine
manufactured by MassBiologics and with labeled indications for the same use as Tenivac ®, has indicated that they have sufficient supply available to address the historical demand for Td vaccine during this time period. Updated Nov 2016
 Vaccine Information Statements (VISs)
o https://www.cdc.gov/vaccines/hcp/vis/index.html
INSURANCE
 America’s Health Insurance
o https://www.cdc.gov/features/marketplace/index.html
NEWS
 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
o https://www.cdc.gov/niosh/docs/2016-161/
 Study: Fake retailer apps bedevil mobile shoppers
o http://www.retaildive.com/news/study-fake-retailer-apps-bedevil-mobile-shoppers/429644/
 Seven substances added to 14th Report on Carcinogens
o https://www.nih.gov/news-events/news-releases/seven-substances-added-14th-report-carcinogens
 Caffeine, MSG May Trigger Migraine
o http://www.consultant360.com/exclusives/caffeine-msg-may-trigger-migraine
 Oral Cancer Diagnoses Claims Rise 61% Over 4 Years
o http://www.managedhealthcareconnect.com/content/oral-cancer-diagnoses-claims-rise-61-over-4-years





 Low-Carb Diet Could Help Lower Insulin Resistance
o http://www.consultant360.com/exclusives/low-carb-diet-could-help-lower-insulin-resistance







 The ethics of prescribing less effective but more affordable treatments
o http://www.journalofclinicalpathways.com/news/ethics-prescribing-less-effective-more-affordable-treatments
 Pfizer and FDA: Expedited regulatory pathways ignore manufacturing burdens
o http://www.in-pharmatechnologist.com/Regulatory-Safety/Expedited-regulatory-pathways-ignore-manufacturing-burdens-AAPS-
panel
 Study Examines Cost-Effectiveness of Treatment Sequencing for HER2-Positive Breast Cancer
o http://www.journalofclinicalpathways.com/issue
 FDA research to help speed development of Zika virus vaccines and therapeutics
o http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm529740.htm?source=govdelivery&utm_medium=email&utm_
source=govdelivery
 Top 10 Pharmafocus issues for November
o http://raps.informz.net/informzdataservice/onlineversion/ind/bWFpbGluZ2luc3RhbmNlaWQ9NTcxNzc5NCZzdWJzY3JpYmVyaWQ9OD
MzNDk2MDQy
 Improving Diabetes Awareness Through Managed Care
o http://www.managedhealthcareconnect.com/resource-center/diabetes
 Diabetic Older Adults: Drug Use and Interactions
o http://www.diabetesmanagedmarkets.com/
 Annals of Long-Term Care November 2016
o http://www.managedhealthcareconnect.com/content/volume-24-issue-10-november-2016-altc





 Study: Light Walking Could Significantly Improve Insulin Sensitivity In Diabetes Patients
o http://www.consultant360.com/topic/diabetes
 Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective
o http://www.health.harvard.edu/blog/anti-inflammatory-medications-and-the-risk-for-cardiovascular-disease-a-new-study-a-new-
perspective-2016112310725
 Strengthening Data Security From End To End
o http://www.healthitoutcomes.com/doc/strengthening-data-security-from-end-to-end-0001?vm_tId=1966583&user=ffdb479f-a19f-
466b-abb0-55d4329c64fa&utm_source=et_6231164&utm_medium=email&utm_campaign=HCIT_11-29-2016&utm_term=ffdb479f-
a19f-466b-abb0-55d4329c64fa&utm_content=Strengthening+Data+Security+From+End+To+End
